Clinical Trial Update: MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of durvalumab (MEDI4736) in patients with brain metastases from epithelial-derived tumors, with terminated status and results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastroesophageal Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Renal Cancer

Drugs mentioned

• MEDI4736 (Durvalumab) (durvalumab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-10-10